PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules

被引：0
|
作者：
Shibo Qi
Susan Hoppmann
Yingding Xu
Zhen Cheng
机构：
[1] Tianjin Polytechnic University,School of Environmental and Chemical Engineering
[2] Stanford University,Molecular Imaging Program at Stanford (MIPS), Department of Radiology, and Bio
来源：
Molecular Imaging and Biology | 2019年 / 21卷
关键词：
PET; Affibody; HER2; Cu-64; Tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [41] A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
    Ren, Gang
    Zhang, Rong
    Liu, Zhe
    Webster, Jack M.
    Miao, Zheng
    Gambhir, Sanjiv S.
    Syud, Faisal A.
    Cheng, Zhen
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) : 1492 - 1499
  • [42] Targeted PLGA-Chitosan Nanoparticles for NIR-Triggered Phototherapy and Imaging of HER2-Positive Tumors
    Kotelnikova, Polina A.
    Shipunova, Victoria O.
    Deyev, Sergey M.
    PHARMACEUTICS, 2024, 16 (01)
  • [43] 64Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor
    Kruziki, Max A.
    Case, Brett A.
    Chan, Jie Y.
    Zudock, Elizabeth J.
    Woldring, Daniel R.
    Yee, Douglas
    Hackel, Benjamin J.
    MOLECULAR PHARMACEUTICS, 2016, 13 (11) : 3747 - 3755
  • [44] A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT
    Chan, Conrad
    Scollard, Deborah A.
    McLarty, Kristin
    Smith, Serena
    Reilly, Raymond M.
    EJNMMI RESEARCH, 2011, 1 : 1 - 11
  • [45] Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer
    Hunter, Natasha B.
    Peterson, Lanell M.
    Specht, Jennifer M.
    Mankoff, David A.
    Muzi, Mark
    Chen, Delphine L.
    Gwin, William R.
    Vinayak, Shaveta
    Davidson, Nancy E.
    Linden, Hannah M.
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [46] Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [99mTc]-(I)-Tricarbonyl Complex
    Valerie J. Facca
    Noor Al-saden
    Anthony Ku
    Raymond M. Reilly
    Molecular Imaging and Biology, 2021, 23 : 495 - 504
  • [47] 64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents
    Kwon, Luke Yongkyu
    Scollard, Deborah A.
    Reilly, Raymond M.
    MOLECULAR PHARMACEUTICS, 2017, 14 (02) : 492 - 501
  • [48] Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 Affibody for single-photon imaging of HER2 expression in tumors
    Orlova, Anna
    Nilsson, Fredrik Y.
    Wikman, Maria
    Widstrom, Charles
    Stahl, Stefan
    Carlsson, Jorgen
    Tolmachev, Vladimir
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (03) : 512 - 519
  • [49] Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
    Dijkers, E. C.
    Munnink, T. H. Oude
    Kosterink, J. G.
    Brouwers, A. H.
    Jager, P. L.
    de Jong, J. R.
    van Dongen, G. A.
    Schroder, C. P.
    Lub-de Hooge, M. N.
    de Vries, E. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) : 586 - 592
  • [50] Kit for the preparation of 111In-labeled pertuzumab injection for imaging response of HER2-positive breast cancer to trastuzumab (Herceptin)
    Lam, Karen
    Scollard, Deborah A.
    Chan, Conrad
    Levine, Mark N.
    Reilly, Raymond M.
    APPLIED RADIATION AND ISOTOPES, 2015, 95 : 135 - 142
12345